Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.
Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data.
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury.
Multiple Sclerosis.
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Disability profile of multiple sclerosis in New Zealand.
Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Cutting Edge: c-Kit Signaling Differentially Regulates Type 2 Innate Lymphoid Cell Accumulation and Susceptibility to Central Nervous System Demyelination in Male and Female SJL Mice.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Role of executive functions in prospective memory in multiple sclerosis: Impact of the strength of cue-action association.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.

Pages